The efficacy of anti-IL-1β antibody was previously proven in the treatment of asthmatic guinea pigs (37), and the present study also supports a therapeutic value for anti-IL-1β antibody in the treatment of refractory asthma. The gene discussed is IL1B; the disease is asthma.